维普期刊资源整合服务平台（V6.5）

39篇 您的检索式：作者名="Colozza M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Value of Ki67 in breast cancer: the debate is still open 显示文摘	Colozza M Sidoni A Piccart-Gebhart M	2010	Lancet On col2010，11，5：	1
2	EGFR,pMAPK,pAkt and PTEN status by immunohistochemistry:correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab显示文摘	Gori S Sidoni A Colozza M Ferri I Mameli MG Fenocchio D	2009	Ann Oncol2009，20，4：	1
3	Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival 显示文摘	Ludovini V Gori S Colozza M	2008	Ann Oncol2008，19，5：	1
4	Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: A prospective randomized study显示文摘	Colozza M Bisagni G Mosconi A	2002	Eur J Cancer2002，38，：	1
5	CagA and VacA Helicobaeter pylori antibodies in gastric cancer显示文摘	Suriani R Colozza M Cardesi E	2008	Can J Gastroenterol2008，22，3：	1
6	CagA and VacA Helicobacter pylori antibodies in gastric cancer显示文摘	Suriani R Colozza M Cardesi E	2008	Cancer J Gastroenterol2008，22，3：	1
7	CagA and VacA Helicobacter pylori antibodies in gastric cancer显示文摘	Suriani R Colozza M Cardesi E	2008	Cancer J Gastroenterol2008，22，3：	1
8	Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?显示文摘	Colozza M Azambuja E Cardoso F	2005	Ann Oncol2005，16，11：	1
9	Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer:A prospective randomized study显示文摘	Colozza M Bisagni G Mosconi A	2012	Eur J Cancer2012，38，17：	1
10	Evaluation of serum HER2 extracellular domain in early breast cancer pa- tients: correlation with clinicopathological parameters and survival显示文摘	Ludovini V Gori S Colozza M	2008	Ann Oncol2008，19，5：	1
11	Long-tern1 toxic effects of adjuvant chemotherapy in breast cancer显示文摘	Azim HA Jr de Azambuja E Colozza M	2011	Ann Oncol2011，22，9：	1
12	Evaluation of serum HER2 extracellular domain in early breast cancer patients: cor- relation with clinicopathological parameters and survival 显示文摘	Ludovini V Gori S Colozza M	2008	Ann Oneol2008，19，5：	1
13	Breast cancer:achievements in adjuvant systemic therapies in the pre-genomic era显示文摘	Colozza M de Azambuja E Cardoso F	2006	Oncologist2006，11，：	1
14	CagA and VacA Helicobacter pylori antibodies in gastric cancer 显示文摘	Suriani R Colozza M Cardesi E	2008	Cancer J Gastroenterol2008，22，3：	1
15	Long-term toxic effects of adjuvant chemotherapy in breast cancer显示文摘	Azim HA Jr de Azambuja E Colozza M	2011	Ann Oncol2011，22，9：	1
16	Proliferative markers as prognostic and predictive tools in early breast cancer: where are we- now? 显示文摘	Colozza M Azambuja E Cardoso F	2005	Ann Oncol2005，16，11：	1
17	Achievements in systemic therapies in the pregenomic era in metastatic breast cancer显示文摘	Colozza M de Azambuja E Personeni N	2007	Oncologist2007，12，：	1
18	CagA and VacA Helicobacter pylori antibodies in gastric cancer显示文摘	Suriani R Colozza M Cardesi E	2008	Can J Gastroenterol2008，22，3：	1
19	Breast cancer:achievement systemic therapies in pre-genomic era显示文摘	Colozza M Azambuja E Cardoso F	2006	Oncologist2006，11，2：	1
20	Proliferative markers as prognostic and predictive tools in early breast cancer: Where are we now? 显示文摘	Colozza M Azambuja E Cardoso F	2005	Ann Oncol2005，16，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示